Young-Min Ye Selected Research

Cefaclor (Ceclor)

2/2021	Clinical characteristics and risk factors for cefaclor-induced immediate hypersensitivity: a retrospective observation at two university hospitals in Korea.
1/2021	Cefaclor-induced hypersensitivity: Differences in the incidence of anaphylaxis relative to other 2nd and 3rd generation cephalosporins.
11/2014	Immunologic evaluation of immediate hypersensitivity to cefaclor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Young-Min Ye Research Topics

Disease

39	Asthma (Bronchial Asthma) 02/2021 - 06/2006
34	Hypersensitivity (Allergy) 01/2021 - 07/2006
23	Urticaria (Hives) 02/2022 - 08/2006
23	Chronic Urticaria 02/2022 - 02/2007
15	Inflammation (Inflammations) 01/2021 - 06/2006
14	Anaphylaxis (Anaphylactic Shock) 02/2021 - 05/2011
9	Occupational Asthma 01/2018 - 09/2008
8	Drug-Related Side Effects and Adverse Reactions 02/2021 - 07/2011
5	Angioedema 01/2021 - 08/2006
4	Immediate Hypersensitivity 02/2021 - 11/2012
4	Rhinitis 05/2014 - 04/2010
3	Allergic Rhinitis 12/2019 - 10/2012
3	Tuberculosis (Tuberculoses) 01/2019 - 01/2010
3	Rhinosinusitis 03/2015 - 04/2010
3	Atopic Dermatitis (Atopic Eczema) 01/2015 - 03/2012
3	Pain (Aches) 01/2014 - 10/2009
3	Exercise-Induced Allergies 11/2013 - 11/2008
2	Communicable Diseases (Infectious Diseases) 02/2021 - 11/2014
2	Respiratory Hypersensitivity 01/2021 - 10/2006
2	Abdominal Pain (Pain, Abdominal) 12/2019 - 05/2011
2	Drug Hypersensitivity (Drug Allergy) 01/2019 - 11/2012
2	Skin Diseases (Skin Disease) 01/2017 - 10/2008
2	Virus Diseases (Viral Diseases) 08/2016 - 01/2014
2	Stevens-Johnson Syndrome (Lyell's Syndrome) 08/2016 - 08/2010
2	Food Hypersensitivity (Food Allergy) 03/2016 - 07/2010
2	Delayed Hypersensitivity (Hypersensitivity, Type IV) 03/2015 - 07/2011
2	Dizziness (Lightheadedness) 01/2014 - 05/2011
2	Genetic Predisposition to Disease (Genetic Predisposition) 11/2012 - 04/2007
2	Eosinophilia 07/2011 - 04/2010
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2007 - 06/2006
1	Hypertension (High Blood Pressure) 02/2021
1	Liver Diseases (Liver Disease) 02/2021

Drug/Important Bio-Agent (IBA)

30	Immunoglobulin E (IgE)IBA 02/2022 - 08/2006
27	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 06/2006
8	AllergensIBA 01/2015 - 07/2006
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2006
7	Pharmaceutical PreparationsIBA 08/2020 - 08/2010
7	AutoantibodiesIBA 02/2020 - 06/2006
7	Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA 01/2018 - 10/2006
7	AntibodiesIBA 06/2015 - 06/2006
6	Histamine Antagonists (Antihistamines)IBA 02/2020 - 03/2009
6	Immunoglobulin G (IgG)IBA 02/2020 - 06/2006
6	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2012 - 07/2006
5	EnzymesIBA 01/2021 - 08/2010
4	Cephalosporins (Cephalosporin Antibiotics)IBA 02/2021 - 03/2012
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2006
4	CytokinesIBA 01/2021 - 09/2007
4	IgE Receptors (Fc epsilon RI)IBA 02/2020 - 08/2006
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2016 - 08/2010
4	Histamine (Histamine Dihydrochloride)FDA Link 05/2016 - 08/2006
4	Genetic Markers (Genetic Marker)IBA 01/2014 - 08/2006
3	Omalizumab (Xolair)FDA Link 02/2022 - 11/2012
3	Cefaclor (Ceclor)FDA LinkGeneric 02/2021 - 11/2014
3	Interleukin-13IBA 01/2021 - 10/2009
3	Carbamazepine (Tegretol)FDA LinkGeneric 01/2021 - 08/2010
3	PeriostinIBA 01/2020 - 09/2014
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2015 - 08/2010
3	GliadinIBA 11/2013 - 11/2008
3	LeukotrienesIBA 08/2010 - 08/2006
3	Interleukin-10 (Interleukin 10)IBA 01/2010 - 06/2006
3	AutoantigensIBA 07/2009 - 08/2006
2	ImmunosorbentsIBA 01/2021 - 09/2014
2	Interleukin-4 (Interleukin 4)IBA 01/2021 - 11/2013
2	Allopurinol (Remid)FDA LinkGeneric 01/2021 - 08/2010
2	Vancomycin FDA LinkGeneric 01/2021 - 07/2011
2	Arthropod VenomsIBA 08/2020 - 09/2012
2	Formoterol Fumarate (Oxis)FDA Link 04/2020 - 04/2009
2	Budesonide (Pulmicort)FDA LinkGeneric 04/2020 - 04/2009
2	Complement System Proteins (Complement)IBA 02/2020 - 07/2010
2	Ethambutol (Myambutol)FDA LinkGeneric 01/2019 - 01/2010
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2019 - 01/2010
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2019 - 01/2010
2	Histamine Receptors (Histamine Receptor)IBA 01/2019 - 08/2006
2	Pyrazinamide FDA LinkGeneric 01/2019 - 01/2010
2	ClusterinIBA 01/2018 - 05/2016
2	Ofloxacin (Ofloxacine)FDA LinkGeneric 08/2017 - 11/2012
2	Acetaminophen (Paracetamol)FDA LinkGeneric 03/2017 - 08/2016
2	Filaggrin ProteinsIBA 01/2017 - 06/2014
2	Contrast MediaIBA 03/2015 - 01/2015
2	CholesterolIBA 01/2015 - 03/2013
2	Lamotrigine (Lamictal)FDA LinkGeneric 08/2014 - 08/2010
2	SuperantigensIBA 05/2014 - 10/2008
2	anti-IgE antibodiesIBA 10/2012 - 09/2012
2	SteroidsIBA 09/2012 - 10/2011
2	Human Serum Albumin FDA LinkGeneric 03/2012 - 05/2011
2	Adrenergic Receptors (Adrenergic Receptor)IBA 05/2011 - 12/2007
2	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 08/2010 - 05/2008
2	PowdersIBA 04/2010 - 01/2010
2	Protein Glutamine gamma Glutamyltransferase 2IBA 11/2009 - 06/2006
2	Phosphopyruvate Hydratase (Enolase)IBA 07/2009 - 08/2006
2	Keratin-18 (Keratin 18)IBA 07/2009 - 08/2006
2	4,4'-diphenylmethane diisocyanate (methylene diphenyl diisocyanate)IBA 10/2008 - 09/2008
2	Immunoglobulin A (IgA)IBA 03/2008 - 06/2006
2	Leukotriene C4IBA 11/2007 - 08/2006
2	Interleukin-6 (Interleukin 6)IBA 09/2007 - 06/2006
2	Methacholine Chloride (Methacholine)FDA Link 10/2006 - 06/2006
2	AntigensIBA 08/2006 - 08/2006
1	Monoclonal AntibodiesIBA 02/2022

Therapy/Procedure

5	Therapeutics 01/2019 - 08/2006
2	Polypharmacy 12/2020 - 01/2016